Intriguingly, despite more modest expression in our analyses, MSI2 has also been characterized as a pivotal tumorigenic marker and a marker of reduced OS in mantle cell lymphoma (Sureda-Gómez et al., 2023). This evidence concerns the gene MSI2 and mantle cell lymphoma.